ADMA Biologics, Inc.
ADMA
$17.02
$0.110.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.00% | 80.06% | 200.92% | -787.63% | 140.28% |
| Total Depreciation and Amortization | -5.23% | -3.17% | 0.67% | 0.38% | -0.29% |
| Total Amortization of Deferred Charges | 11.01% | -10.28% | -64.23% | -1.91% | 4.95% |
| Total Other Non-Cash Items | 11.38% | 32.94% | -92.62% | 950.34% | 6.07% |
| Change in Net Operating Assets | -291.30% | 134.59% | -780.78% | -6.72% | 176.29% |
| Cash from Operations | -45.17% | 2,157.98% | -112.61% | 46.82% | 297.80% |
| Capital Expenditure | 48.89% | 11.97% | -96.04% | -58.15% | 13.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.95% | -1,893.33% | 92.86% | -- | -- |
| Cash from Investing | 53.57% | -0.13% | -67.85% | -85.89% | 13.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 1,619.34% | -67.83% | 12,005.88% | -98.64% | 32.20% |
| Repurchase of Common Stock | -67.10% | 72.01% | -627.17% | -63.70% | 7.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6,935.08% | 74.98% | 96.29% | -9,473.56% | 73.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.58% | 812.11% | 73.57% | -295.85% | 274.02% |
